MAPT and Parkinson disease: Concerning in vivo tau deposition evaluation, cortical 18F-AV-1451 uptake was more significant in DLB than in the controls or cognitively normal PD, especially in the inferior temporal gyrus and precuneus, where increased binding resulted associated with cognitive impairment.